4.1 Article

CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis

Yuming Niu et al.

MOLECULAR BIOLOGY REPORTS (2012)

Letter Oncology

The association between AURKA T91A polymorphism and breast cancer risk

Chibo Liu

BREAST CANCER RESEARCH AND TREATMENT (2011)

Article Oncology

Association between CYP2E1 genetic polymorphisms and lung cancer risk: A meta-analysis

Yadong Wang et al.

EUROPEAN JOURNAL OF CANCER (2010)

Article Gastroenterology & Hepatology

CYP2E1 Pst I/Rsa I polymorphism and colorectal cancer risk: A meta-analysis

Guo-Wu Zhou et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

Asmaa Ibrahim Gomaa et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Review Multidisciplinary Sciences

Adaptive immune responses in acute and chronic hepatitis C virus infection

DG Bowen et al.

NATURE (2005)

Article Oncology

Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma

M Munaka et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)